Pages that link to "Q81504151"

The following pages link to Early stage prostate cancer--do we have a problem with over-detection, overtreatment or both? (Q81504151):

Displaying 36 items.

• Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer (Q28541215) (← links)
• Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer (Q28553603) (← links)
• Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores (Q33621918) (← links)
• Incremental value of magnetic resonance imaging in the advanced management of prostate cancer (Q33772524) (← links)
• Patient perspective on watchful waiting/active surveillance for localized prostate cancer (Q34419421) (← links)
• Metastasis as a therapeutic target in prostate cancer: a conceptual framework. (Q34448162) (← links)
• Biopsy follow-up of prostate-specific antigen tests (Q36567436) (← links)
• Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml (Q36837061) (← links)
• Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI. (Q36837246) (← links)
• A new approach to understanding racial disparities in prostate cancer treatment (Q36971869) (← links)
• Five-year downstream outcomes following prostate-specific antigen screening in older men (Q37017183) (← links)
• Clinical significance of NUCB2 mRNA expression in prostate cancer (Q37116462) (← links)
• Advances in MR spectroscopy of the prostate (Q37300338) (← links)
• Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer (Q37367755) (← links)
• miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma (Q37707562) (← links)
• Pathological characterization of unifocal prostate cancers in whole‐mount radical prostatectomy specimens (Q37808281) (← links)
• Prostate cancer detection after a negative prostate biopsy: Lessons learnt in the Cleveland Clinic experience (Q37892629) (← links)
• Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma (Q38771232) (← links)
• Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer (Q38798431) (← links)
• Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading (Q39301749) (← links)
• Prognostic value of transformer 2β expression in prostate cancer (Q41494839) (← links)
• Kinetic and perfusion modeling of hyperpolarized (13)C pyruvate and urea in cancer with arbitrary RF flip angles (Q41889355) (← links)
• Survival from prostate cancer in England and Wales up to 2001. (Q42126757) (← links)
• Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy (Q42271033) (← links)
• Metabolic syndrome and prostate cancer (Q46650533) (← links)
• Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer (Q47635662) (← links)
• The prognostic value of abnormally expressed lncRNAs in prostatic carcinoma: A systematic review and meta-analysis (Q49486523) (← links)
• Technique development of 3D dynamic CS-EPSI for hyperpolarized 13 C pyruvate MR molecular imaging of human prostate cancer. (Q52633673) (← links)
• The changing face of prostate cancer: can gains in epigenetic knowledge translate into improvements in clinical care? (Q79190665) (← links)
• Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience (Q80491705) (← links)
• Staging saturation biopsy in patients with prostate cancer on active surveillance protocol (Q81012791) (← links)
• Using a saturation biopsy scheme increases cancer detection during repeat biopsy in men with high-grade prostatic intra-epithelial neoplasia (Q82350503) (← links)
• Is Population Screening for Prostate Cancer Good or Bad? (Q82938613) (← links)
• Office Based Transrectal Saturation Biopsy Improves Prostate Cancer Detection Compared to Extended Biopsy in the Repeat Biopsy Population (Q84592313) (← links)
• Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillance (Q85776030) (← links)
• Editorial comment (Q95482811) (← links)